Cargando…
SAT549 False Alarm: Profoundly High Thyroglobulin Level Without Evidence Of Thyroid Malignancy
Disclosure: F.L. Thelmo: None. J. Watari: None. J.L. Miller: None. Thyroglobulin (TG) remains a clinical mainstay for monitoring of disease burden and recurrence in patients with differentiated thyroid cancer. TG levels are expected to be low to undetectable in patients who undergo total thyroidecto...
Autores principales: | Thelmo, Franklin L, Watari, Jessica, Miller, Jeffrey L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555777/ http://dx.doi.org/10.1210/jendso/bvad114.2020 |
Ejemplares similares
-
SAT573 Incidental Discovery Of CHEK2 Mutation With Papillary Thyroid Cancer
por: Thelmo, Franklin L, et al.
Publicado: (2023) -
SUN-625 A False Alarm: Elevated Thyroglobulin Levels in a Patient Receiving Intravenous Immunoglobulin
por: Zia, Maryam, et al.
Publicado: (2019) -
SAT-614 False-Positive in Measurement of Thyroglobulin in a Patient with Mixed Connective Tissue Disease
por: Maciel, Ana Alice, et al.
Publicado: (2019) -
SAT546 Papillary Thyroid Cancer Surveillance: Thyroglobulin Levels Affected by HAMA
por: Perez, Julienne Sanchez, et al.
Publicado: (2023) -
Utility of Stimulated Thyroglobulin in the Differentiate Thyroid Cancer
por: Romero, Fabiola, et al.
Publicado: (2021)